Tostran 2% gel

Country: Bretland

Tungumál: enska

Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)

Virkt innihaldsefni:

Testosterone

Fáanlegur frá:

Kyowa Kirin Ltd

ATC númer:

G03BA03

INN (Alþjóðlegt nafn):

Testosterone

Skammtar:

20mg/1gram

Lyfjaform:

Transdermal gel

Stjórnsýsluleið:

Transdermal

Tegund:

Schedule 4 (CD Anab)

Gerð lyfseðils:

Valid as a prescribable product

Vörulýsing:

BNF: 06040200; GTIN: 5038903000358 5038903000389

Upplýsingar fylgiseðill

PACKAGE LEAFLET: INFORMATION FOR THE USER
TOSTRAN
® 2% GEL
Testosterone
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed
in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Tostran is and what it is used for
2.
What you need to know before you use Tostran
3.
How to use Tostran
4.
Possible side effects
5.
How to store Tostran
6.
Contents of the pack and other information
1. WHAT TOSTRAN IS AND WHAT IT IS USED FOR
The active substance, testosterone, is a male hormone, which is a type
of androgen.
Tostran is used in adult men for testosterone replacement to treat
various health problems caused by a
lack of testosterone (male hypogonadism). This should be confirmed by
two separate blood testosterone
measurements and also include clinical symptoms such as:
•
impotence
•
infertility
•
low sex drive
•
tiredness
•
depressive moods
•
bone loss caused by low hormone levels
2. WHAT YOU NEED TO KNOW BEFORE YOU USE TOSTRAN
Tostran must only be used if hypogonadism has been confirmed by your
doctor, based on your symptoms and
laboratory tests. Other reasons for your symptoms must have been
excluded by your doctor prior to the start of
treatment.
Only men can use Tostran. Tostran has not been tested in males less
than 18 years of age, and there is limited
experience of treating men older than 65 years of age.
DO NOT USE TOSTRAN:
If you:
-
are allergic to testosterone or any of the other ingredients of this
medicine (listed in section 6.)
-
have or are suspected of having cancer of the breast or prostate
If any of these applies to you, tell your docto

Vara einkenni

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Tostran 2% Gel.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One gram of gel contains 20 mg testosterone. One press of the canister
piston
delivers 0.5 g of gel containing 10 mg testosterone.
Excipient(s) with known effect:
One gram of gel contains 1 mg butylhydroxytoluene.
One gram of gel contains 350 mg propylene glycol.
For the full list of excipients, see Section 6.1.
3
PHARMACEUTICAL FORM
Gel.
Clear, colourless to slightly yellow gel.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Testosterone replacement therapy for male hypogonadism when
testosterone deficiency has
been confirmed by clinical features and biochemical tests.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and Elderly Men _
The recommended starting dose of Tostran is 3 g gel (60 mg of
testosterone) applied once
daily at approximately the same time each morning. Dose titration
should be based on both
serum testosterone levels and the existence of clinical signs and
symptoms related to
androgen deficiency. It should be taken into account that
physiological testosterone levels
decline with increasing age.
The daily dose should not exceed 4 g of gel (80 mg testosterone).
_Paediatric Population _
Tostran is not indicated for use in children and has not been
clinically evaluated in males
under 18 years of age.
_Method of administration _
For cutaneous use
The dose can be applied to the abdomen (entire dose over an area of at
least 10 by 30 cm), or
to BOTH inner thighs (one half of the dose over an area of at least 10
by 15 cm for each inner
thigh). Daily rotation between the abdomen and inner thighs is
recommended to minimise
application site reactions.
The gel should be applied to clean, dry, intact skin. It should be
rubbed in gently with one
finger until dry, then the application site should be covered,
preferably with loose clothing.
Hands should then be washed with soap and water.
Each full depression of the canister piston delivers one half gram of
gel (10 mg tes